{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:50:28Z","timestamp":1794437428376,"version":"4.9.1"},"publisher-location":"Totowa, NJ","reference-count":53,"publisher":"Humana Press","isbn-type":[{"value":"9781627032292","type":"print"},{"value":"9781627032308","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,11,4]],"date-time":"2012-11-04T00:00:00Z","timestamp":1351987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,11,4]],"date-time":"2012-11-04T00:00:00Z","timestamp":1351987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-230-8_16","type":"book-chapter","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T11:09:54Z","timestamp":1357556994000},"page":"265-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["RAGE Splicing Variants in Mammals"],"prefix":"10.1007","author":[{"given":"Katharina Anna","family":"Sterenczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Murua","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,4]]},"reference":[{"key":"16_CR00161","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper M et al (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998\u201315004","journal-title":"J Biol Chem"},{"key":"16_CR00162","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1084\/jem.20030800","volume":"198","author":"T Chavakis","year":"2003","unstructured":"Chavakis T et al (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198:1507\u20131515","journal-title":"J Exp Med"},{"key":"16_CR00163","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97:889\u2013901","journal-title":"Cell"},{"key":"16_CR00164","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori O et al (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270:25752\u201325761","journal-title":"J Biol Chem"},{"key":"16_CR00165","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD et al (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382:685\u2013691","journal-title":"Nature"},{"key":"16_CR00166","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1006\/geno.1994.1517","volume":"23","author":"K Sugaya","year":"1994","unstructured":"Sugaya K et al (1994) Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23:408\u2013419","journal-title":"Genomics"},{"key":"16_CR00167","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1006\/geno.1994.1676","volume":"24","author":"H Vissing","year":"1994","unstructured":"Vissing H et al (1994) Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3. Genomics 24:606\u2013608","journal-title":"Genomics"},{"key":"16_CR00168","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","volume":"108","author":"AM Schmidt","year":"2001","unstructured":"Schmidt AM et al (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949\u2013955","journal-title":"J Clin Invest"},{"key":"16_CR00169","doi-asserted-by":"publisher","first-page":"29923","DOI":"10.1074\/jbc.273.45.29923","volume":"273","author":"AA Deora","year":"1998","unstructured":"Deora AA et al (1998) A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3\u2032-kinase to Ras by redox stress. J Biol Chem 273:29923\u201329928","journal-title":"J Biol Chem"},{"key":"16_CR001610","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y","volume":"81","author":"JS Huang","year":"2001","unstructured":"Huang JS et al (2001) Role of receptor for advanced glycation end-product (RAGE) and the JAK\/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 81:102\u2013113","journal-title":"J Cell Biochem"},{"key":"16_CR001611","doi-asserted-by":"publisher","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","volume":"274","author":"HJ Huttunen","year":"1999","unstructured":"Huttunen HJ, Fages C, Rauvala H (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274:19919\u201319924","journal-title":"J Biol Chem"},{"key":"16_CR001612","doi-asserted-by":"publisher","first-page":"38635","DOI":"10.1074\/jbc.M202515200","volume":"277","author":"HJ Huttunen","year":"2002","unstructured":"Huttunen HJ, Kuja-Panula J, Rauvala H (2002) Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 277:38635\u201338646","journal-title":"J Biol Chem"},{"key":"16_CR001613","doi-asserted-by":"publisher","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","volume":"274","author":"T Kislinger","year":"1999","unstructured":"Kislinger T et al (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740\u201331749","journal-title":"J Biol Chem"},{"key":"16_CR001614","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1074\/jbc.272.28.17810","volume":"272","author":"HM Lander","year":"1997","unstructured":"Lander HM et al (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810\u201317814","journal-title":"J Biol Chem"},{"key":"16_CR001615","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","volume":"269","author":"SD Yan","year":"1994","unstructured":"Yan SD et al (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins. J Biol Chem 269:9889\u20139897","journal-title":"J Biol Chem"},{"key":"16_CR001616","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","volume":"108","author":"F Cipollone","year":"2003","unstructured":"Cipollone F et al (2003) The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108:1070\u20131077","journal-title":"Circulation"},{"key":"16_CR001617","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park L et al (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025\u20131031","journal-title":"Nat Med"},{"key":"16_CR001618","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9440(10)61723-3","volume":"159","author":"MT Goova","year":"2001","unstructured":"Goova MT et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513\u2013525","journal-title":"Am J Pathol"},{"key":"16_CR001619","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF et al (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol 171:29\u201345","journal-title":"Exp Neurol"},{"key":"16_CR001620","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1568007054038210","volume":"4","author":"LF Lue","year":"2005","unstructured":"Lue LF et al (2005) Preventing activation of receptor for advanced glycation endproducts in Alzheimer\u2019s disease. Curr Drug Targets CNS Neurol Disord 4:249\u2013266","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"16_CR001621","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.gene.6363861","volume":"3","author":"MA Hofmann","year":"2002","unstructured":"Hofmann MA et al (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123\u2013135","journal-title":"Genes Immun"},{"key":"16_CR001622","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.micinf.2004.08.004","volume":"6","author":"T Chavakis","year":"2004","unstructured":"Chavakis T, Bierhaus A, Nawroth PP (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 6:1219\u20131225","journal-title":"Microbes Infect"},{"key":"16_CR001623","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/35012626","volume":"405","author":"A Taguchi","year":"2000","unstructured":"Taguchi A et al (2000) Blockade of RAGE-amphoterin signalling suppresses tumor growth and metastases. Nature 405:354\u2013360","journal-title":"Nature"},{"key":"16_CR001624","first-page":"4805","volume":"62","author":"HJ Huttunen","year":"2002","unstructured":"Huttunen HJ et al (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62:4805\u20134811","journal-title":"Cancer Res"},{"key":"16_CR001625","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/carcin\/bgh333","volume":"26","author":"B Bartling","year":"2005","unstructured":"Bartling B et al (2005) Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26:293\u2013301","journal-title":"Carcinogenesis"},{"key":"16_CR001626","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000087910","volume":"69","author":"UK Bhawal","year":"2005","unstructured":"Bhawal UK et al (2005) Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology 69:246\u2013255","journal-title":"Oncology"},{"key":"16_CR001627","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/pros.20219","volume":"64","author":"H Ishiguro","year":"2005","unstructured":"Ishiguro H et al (2005) Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64:92\u2013100","journal-title":"Prostate"},{"key":"16_CR001628","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0169-328X(99)00174-6","volume":"71","author":"P Malherbe","year":"1999","unstructured":"Malherbe P et al (1999) cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res 71:159\u2013170","journal-title":"Brain Res Mol Brain Res"},{"key":"16_CR001629","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbaexp.2003.08.008","volume":"1630","author":"C Schlueter","year":"2003","unstructured":"Schlueter C et al (2003) Tissue-specific expression patterns of the RAGE receptor and its soluble forms\u2014a result of regulated alternative splicing? Biochim Biophys Acta 1630:1\u20136","journal-title":"Biochim Biophys Acta"},{"key":"16_CR001630","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/BJ20021371","volume":"370","author":"H Yonekura","year":"2003","unstructured":"Yonekura H et al (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:1097\u20131109","journal-title":"Biochem J"},{"key":"16_CR001631","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.molimm.2003.11.027","volume":"40","author":"IH Park","year":"2004","unstructured":"Park IH et al (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 40:1203\u20131211","journal-title":"Mol Immunol"},{"key":"16_CR001632","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbamcr.2005.08.006","volume":"1746","author":"Q Ding","year":"2005","unstructured":"Ding Q, Keller JN (2005) Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim Biophys Acta 1746:18\u201327","journal-title":"Biochim Biophys Acta"},{"key":"16_CR001633","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2004.09.059","volume":"373","author":"Q Ding","year":"2005","unstructured":"Ding Q, Keller JN (2005) Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci Lett 373:67\u201372","journal-title":"Neurosci Lett"},{"key":"16_CR001634","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1096\/fj.07-9909com","volume":"22","author":"BI Hudson","year":"2008","unstructured":"Hudson BI et al (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J 22:1572\u20131580","journal-title":"FASEB J"},{"issue":"9","key":"16_CR001635","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","volume":"23","author":"D Geroldi","year":"2005","unstructured":"Geroldi D et al (2005) Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens 23(9):1725\u20131729","journal-title":"J Hypertens"},{"key":"16_CR001636","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1471-4159.2009.05907.x","volume":"108","author":"E Parkin","year":"2009","unstructured":"Parkin E, Harris B (2009) A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J Neurochem 108:1464\u20131479","journal-title":"J Neurochem"},{"key":"16_CR001637","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"Raucci A et al (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22:3716\u20133727","journal-title":"FASEB J"},{"key":"16_CR001638","doi-asserted-by":"publisher","first-page":"35507","DOI":"10.1074\/jbc.M806948200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang L et al (2008) Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 283:35507\u201335516","journal-title":"J Biol Chem"},{"key":"16_CR001639","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2174\/092986709787581888","volume":"16","author":"F Santilli","year":"2009","unstructured":"Santilli F et al (2009) Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 16:940\u2013952","journal-title":"Curr Med Chem"},{"key":"16_CR001640","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11739-009-0300-1","volume":"4","author":"N Vazzana","year":"2009","unstructured":"Vazzana N et al (2009) Soluble forms of RAGE in internal medicine. Intern Emerg Med 4:389\u2013401","journal-title":"Intern Emerg Med"},{"key":"16_CR001641","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/rheumatology\/kep199","volume":"48","author":"H Maillard-Lefebvre","year":"2009","unstructured":"Maillard-Lefebvre H et al (2009) Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology (Oxford) 48:1190\u20131196","journal-title":"Rheumatology (Oxford)"},{"key":"16_CR001642","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","volume":"62","author":"E Emanuele","year":"2005","unstructured":"Emanuele E et al (2005) Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62:1734\u20131736","journal-title":"Arch Neurol"},{"key":"16_CR001643","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4149\/neo_2010_01_055","volume":"57","author":"R Jing","year":"2010","unstructured":"Jing R et al (2010) Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer. Neoplasma 57:55\u201361","journal-title":"Neoplasma"},{"key":"16_CR001644","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/gtmb.2009.0064","volume":"14","author":"RR Jing","year":"2010","unstructured":"Jing RR et al (2010) Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer. Genet Test Mol Biomarkers 14:355\u2013361","journal-title":"Genet Test Mol Biomarkers"},{"key":"16_CR001645","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/cncr.22731","volume":"109","author":"A Takeuchi","year":"2007","unstructured":"Takeuchi A et al (2007) Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma. Cancer 109:2532\u20132540","journal-title":"Cancer"},{"key":"16_CR001646","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1158\/0008-5472.CAN-10-0595","volume":"70","author":"AZ Kalea","year":"2010","unstructured":"Kalea AZ et al (2010) Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res 70:5628\u20135638","journal-title":"Cancer Res"},{"key":"16_CR001647","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1096\/fj.08-117739","volume":"23","author":"AZ Kalea","year":"2009","unstructured":"Kalea AZ et al (2009) Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J 23:1766\u20131774","journal-title":"FASEB J"},{"key":"16_CR001648","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2008.10.027","volume":"434","author":"KA Sterenczak","year":"2009","unstructured":"Sterenczak KA et al (2009) Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 434:35\u201342","journal-title":"Gene"},{"key":"16_CR001649","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2005.10.015","volume":"369","author":"H Murua Escobar","year":"2006","unstructured":"Murua Escobar H et al (2006) Cloning and characterization of the canine receptor for advanced glycation end products. Gene 369:45\u201352","journal-title":"Gene"},{"key":"16_CR001650","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/geno.1999.5947","volume":"61","author":"M Breen","year":"1999","unstructured":"Breen M et al (1999) Reciprocal chromosome painting reveals detailed regions of conserved synteny between the karyotypes of the domestic dog (Canis familiaris) and human. Genomics 61:145\u2013155","journal-title":"Genomics"},{"key":"16_CR001651","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/geno.1999.5989","volume":"62","author":"F Yang","year":"1999","unstructured":"Yang F et al (1999) A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics 62:189\u2013202","journal-title":"Genomics"},{"key":"16_CR001652","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/BJ20051573","volume":"396","author":"A Harashima","year":"2006","unstructured":"Harashima A et al (2006) Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem J 396:109\u2013115","journal-title":"Biochem J"},{"key":"16_CR001653","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/sj.ejhg.5201649","volume":"14","author":"M Khajavi","year":"2006","unstructured":"Khajavi M, Inoue K, Lupski JR (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074\u20131081","journal-title":"Eur J Hum Genet"}],"container-title":["Methods in Molecular Biology","Calcium-Binding Proteins and RAGE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-230-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T03:08:09Z","timestamp":1676776089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-230-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,4]]},"ISBN":["9781627032292","9781627032308"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-230-8_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-62703-230-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,4]]},"assertion":[{"value":"4 November 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}